Results 11 to 20 of about 6,121 (195)

Cost-Effectiveness of [18F] Fluoroethyl-L-Tyrosine for Temozolomide Therapy Assessment in Patients With Glioblastoma [PDF]

open access: yesFrontiers in Oncology, 2019
Background and Purpose: Glioblastomas are the most aggressive of all gliomas. The prognosis of these gliomas, which are classified as grade IV tumors by the World Health Organization (WHO), is poor.
Tristan Baguet   +3 more
doaj   +3 more sources

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

open access: yesEJNMMI Radiopharmacy and Chemistry, 2022
Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
Jun Toyohara   +20 more
doaj   +2 more sources

Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)

open access: yesEJNMMI Radiopharmacy and Chemistry, 2021
Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to describe trends in the field. Results This commentary of highlights has resulted in 19 different topics selected by each member of the ...
Mohammed Al-Qahtani   +18 more
doaj   +1 more source

Fully-automated production of [68Ga]Ga-PentixaFor on the module Modular Lab-PharmTracer [PDF]

open access: yes, 2020
BACKGROUND: PentixaFor is a promising radiopharmaceutical for positron emission tomography in the detection of different tumor entities and other diseases.
Brenner, Winfried   +2 more
core   +1 more source

Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer [PDF]

open access: yes, 2020
Background Several scan parameters for PET imaging with F-18-PSMA-11 such as dosage, acquisition time and scan duration were evaluated to determine the most appropriate scan protocol, as well as the effect of furosemide administration on lesion ...
Achten, Eric   +7 more
core   +2 more sources

Radiotheranostics: fresh impetus of personalized medicine [PDF]

open access: yesDigital Diagnostics, 2021
Radionuclide therapy is a radionuclide therapy based on molecular imaging using various radiopharmaceuticals (RP), allowing in vivo visualization (SPECT, PET) and selectively affecting pathological metabolic processes caused by a tumor.
Pavel O. Rumyantsev
doaj   +1 more source

Automated GMP Production and Preclinical Evaluation of [68Ga]Ga-TEoS-DAZA and [68Ga]Ga-TMoS-DAZA

open access: yesPharmaceutics, 2022
[68Ga]Ga-TEoS-DAZA and [68Ga]Ga-TMoS-DAZA are two novel radiotracers suitable for functional PET liver imaging. Due to their specific liver uptake and biliary excretion, the tracers may be applied for segmental liver function quantification, gall tree ...
Julia Greiser   +5 more
doaj   +1 more source

The influence of generator eluate in radiolabeling PSMA-11 kit with 68Ga

open access: yesBrazilian Journal of Radiation Sciences, 2021
Gaining prominence in clinical practice, the 68Ga, positron emitter radionuclide easily obtained by 68Ge/68Ga generator elution, has shown potential and excellent quality on radiolabeling of peptide for use in positron emission tomography (PET), in ...
Bianca Franchesqueti Vivaldini   +1 more
doaj   +1 more source

Steroidal anti inflammatory drug betamethasone significantly alters level of striatal dopamine in a rat model of Parkinson’s disease [PDF]

open access: yes, 2008
Many scientific efforts have been well done to investigate the effects of anti inflammatory agents on the degenerative brain diseases such as Parkinson’s (PD) or Alzheimer’s disease and their affiliated sings.
Amin Geravand   +4 more
core   +2 more sources

Encapsulation performance of layer-by-layer microcapsules for proteins [PDF]

open access: yes, 2011
This study reports on the encapsulation efficiency of proteins in dextran sulfate/poly-l-arginine-based microcapsules, fabricated via layer-by-layer assembly (LbL).
De Smedt, Stefaan   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy